The Global New Psychoactive Substance Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028.
New psychoactive substances (NPS) are ‘new narcotic or psychotropic substances, in pure or ready form, that are not controlled by the United Nations Convention on Drugs but may pose similar public health threats to those posed by the substance. listed in this Agreement. EMCDDA plays an active role in the monitoring, evaluation and control of new and potentially threatening narcotic and psychotropic drugs (natural and synthetic analogues) emerging on the European drug scene. This page is the starting point to learn more about the NPS and the agency’s work in this area.
(Get 15% Discount on Buying this Report)
A full report of Global New Psychoactive Substance Market is available at: https://orionmarketreports.com/new-psychoactive-substance-market/88719/
Market Segments
Based on product type
- Stimulants
- Cannabinoids
- Hallucinogens
- Depressants
Based on Indication
- Cancer
- Neuropathic Disorders
- spasticity
Key Players
- Zynerba Pharmaceuticals
- GW Pharmaceuticals PLC.
- Enecta.
- Teewinot Life Sciences
- GD Pharma
- Cape Bouvard Technologies Pty Ltd
- AusCann Group Holdings Pty Ltd.
- Cannabics Pharmaceuticals Inc.
- Alpha-CAT
- Tilray
- Cyrelian Pty Ltd.
- MedReleaf Australia.
Scope of the Report
The research study analyzes the global New Psychoactive Substance industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent Developments
o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment
Geographic Coverage
o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume
Key Questions Answered by New Psychoactive Substance Market Report
1. What was the New Psychoactive Substance Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).
2. What will be the CAGR of New Psychoactive Substance Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the New Psychoactive Substance Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
The report covers the following objectives:
- Proliferation and maturation of trade in the global New Psychoactive Substance market.
- The market share of the global New Psychoactive Substance market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the global New Psychoactive Substance market.
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global New Psychoactive Substance market.
About Us:
Orion Market Reports (OMR) endeavors to provide an exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and the most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
